IFAD Autos PLC. (DSE:IFADAUTOS)
Bangladesh · Delayed Price · Currency is BDT 23.30
0.00 (0.00%)
At close: Jul 31, 2025
Intra-Cellular Therapies Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
| 8,582 | 7,482 | 9,037 | 9,489 | 8,663 | 7,773 | Upgrade | |
Revenue Growth (YoY) | 18.98% | -17.21% | -4.76% | 9.54% | 11.45% | -29.45% | Upgrade |
Cost of Revenue | 7,307 | 6,386 | 7,598 | 7,823 | 7,071 | 6,426 | Upgrade |
Gross Profit | 1,275 | 1,095 | 1,439 | 1,667 | 1,592 | 1,347 | Upgrade |
Selling, General & Admin | 612.95 | 633.17 | 634.08 | 625.79 | 610.87 | 548.68 | Upgrade |
Operating Expenses | 612.95 | 633.17 | 634.08 | 625.79 | 610.87 | 548.68 | Upgrade |
Operating Income | 661.78 | 462.2 | 805.35 | 1,041 | 980.97 | 797.93 | Upgrade |
Interest Expense | -493.9 | -386.93 | -276.6 | -250.08 | -313.25 | -393.96 | Upgrade |
Interest & Investment Income | 122.28 | 98.09 | 90.87 | 85.11 | 105.42 | 118.91 | Upgrade |
Earnings From Equity Investments | 79.15 | 126.43 | 98.66 | 98.34 | 35.6 | 28.43 | Upgrade |
Currency Exchange Gain (Loss) | -210.32 | -196.51 | -608.5 | -247.05 | -0.51 | -10.87 | Upgrade |
Other Non Operating Income (Expenses) | -11.53 | -28.07 | -21.65 | -10.29 | -2.52 | 2.1 | Upgrade |
EBT Excluding Unusual Items | 147.46 | 75.21 | 88.13 | 717.16 | 805.71 | 542.53 | Upgrade |
Gain (Loss) on Sale of Investments | -54.57 | -63.5 | -16.57 | -42.55 | 6.21 | -38.78 | Upgrade |
Gain (Loss) on Sale of Assets | 0.51 | -0.89 | -41.74 | -5.76 | 10.17 | -0 | Upgrade |
Other Unusual Items | 1.7 | 1.7 | 0.45 | 0.22 | 0.72 | 1.09 | Upgrade |
Pretax Income | 95.1 | 12.52 | 30.26 | 669.07 | 822.8 | 504.83 | Upgrade |
Income Tax Expense | 174.33 | 177.06 | 184.01 | 255.07 | 271.62 | 274.93 | Upgrade |
Net Income | -79.22 | -164.55 | -153.75 | 414 | 551.18 | 229.91 | Upgrade |
Net Income to Common | -79.22 | -164.55 | -153.75 | 414 | 551.18 | 229.91 | Upgrade |
Net Income Growth | - | - | - | -24.89% | 139.74% | -79.78% | Upgrade |
Shares Outstanding (Basic) | 268 | 268 | 268 | 268 | 268 | 268 | Upgrade |
Shares Outstanding (Diluted) | 268 | 268 | 268 | 268 | 268 | 268 | Upgrade |
EPS (Basic) | -0.30 | -0.61 | -0.57 | 1.54 | 2.05 | 0.86 | Upgrade |
EPS (Diluted) | -0.30 | -0.61 | -0.57 | 1.54 | 2.05 | 0.86 | Upgrade |
EPS Growth | - | - | - | -24.89% | 139.74% | -79.78% | Upgrade |
Free Cash Flow | -731.79 | -515.81 | -836.22 | 815.19 | -416.44 | -2,359 | Upgrade |
Free Cash Flow Per Share | -2.73 | -1.92 | -3.12 | 3.04 | -1.55 | -8.79 | Upgrade |
Dividend Per Share | 0.099 | 0.099 | 0.990 | 0.471 | 1.037 | 0.832 | Upgrade |
Dividend Growth | -90.00% | -90.00% | 109.99% | -54.54% | 24.66% | -10.01% | Upgrade |
Gross Margin | 14.85% | 14.64% | 15.93% | 17.57% | 18.38% | 17.32% | Upgrade |
Operating Margin | 7.71% | 6.18% | 8.91% | 10.97% | 11.32% | 10.27% | Upgrade |
Profit Margin | -0.92% | -2.20% | -1.70% | 4.36% | 6.36% | 2.96% | Upgrade |
Free Cash Flow Margin | -8.53% | -6.89% | -9.25% | 8.59% | -4.81% | -30.35% | Upgrade |
EBITDA | 751.93 | 556.23 | 906.96 | 1,135 | 1,058 | 864.55 | Upgrade |
EBITDA Margin | 8.76% | 7.43% | 10.04% | 11.96% | 12.21% | 11.12% | Upgrade |
D&A For EBITDA | 90.16 | 94.03 | 101.61 | 93.45 | 76.56 | 66.62 | Upgrade |
EBIT | 661.78 | 462.2 | 805.35 | 1,041 | 980.97 | 797.93 | Upgrade |
EBIT Margin | 7.71% | 6.18% | 8.91% | 10.97% | 11.32% | 10.27% | Upgrade |
Effective Tax Rate | 183.30% | 1414.76% | 608.16% | 38.12% | 33.01% | 54.46% | Upgrade |
Advertising Expenses | - | 3.36 | 3.35 | 2.81 | 5.35 | 10.56 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.